Home
>
US Stocks
>
BioAtla Inc
BioAtla Inc
BCAB

BioAtla Inc (BCAB)

$10.080.1%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$10.28
Today Low/High$9.84 / $10.36
52 Week Low/High$9.82 / $76.63
Market Cap-

Company Details

BioAtla® is a San Diego biotech company that develops novel monoclonal antibody and cell based therapeutics using our proprietary Conditionally Active Biologics™ (CAB) and Comprehensive Integrated Antibody Optimization (CIAO!™) platforms. These and other proprietary technologies (protected by more than 150 issued patents and patent applications) allow it to develop novel biologics (CABs) that are better drugs in multiple ways including more selective targeting of cancer tissue and improved manufacturability. Improved selectivity for the tumor microenvironment (TME), even when the target is also found in normal tissue, not only improves safety and thus therapeutic index but also expands the universe of potential drug targets, enabling the treatment of previously untreatable cancers.
OrganisationBioAtla Inc
Employees36

Discover more

Frequently Asked Questions

What is BioAtla Inc (BCAB) share price today?

Can Indians buy BioAtla Inc (BCAB) shares?

How can I buy BioAtla Inc (BCAB) shares from India?

Can Fractional shares of BioAtla Inc (BCAB) be purchased?

What are the documents required to start investing in BioAtla Inc (BCAB) stocks?